|
2022-08-30 |
2022-08-22 |
B
Purchase
|
Non-Executive Director
|
48,903
+39.5%
465.69
US$1,997,197
|
48,903
+39.5%
|
465.69
|
US$1,997,197
|
|
|
2022-08-19 |
2022-08-19 |
B
Purchase
|
CEO and Chairman of the Board
Executive Director
|
99,454
-43.0%
211.25
US$4,049,880
|
99,454
-43.0%
|
211.25
|
US$4,049,880
|
|
|
2021-11-22 |
2021-11-22 |
B
Purchase
|
CEO and Chairman of the Board
Executive Director
|
18,066
-24.7%
129.43
US$4,540,385
|
18,066
-24.7%
|
129.43
|
US$4,540,385
|
|
|
2021-11-18 |
2021-11-18 |
B
Purchase
|
CEO and Chairman of the Board
Executive Director
|
3,000
+0.1%
1.87
US$5,610
|
3,000
+0.1%
|
1.87
|
US$5,610
|
|
|
2021-11-18 |
2021-11-17 |
B
Purchase
|
Non-Executive Director
|
4,952
+106.9%
2.02
US$10,003
|
4,952
+106.9%
|
2.02
|
US$10,003
|
|
|
2021-11-17 |
2021-11-17 |
B
Purchase
|
Non-Executive Director
|
20,000
+4.8%
2.02
US$40,400
|
20,000
+4.8%
|
2.02
|
US$40,400
|
|
|
2021-11-17 |
2021-11-17 |
B
Purchase
|
Non-Executive Director
|
10,000
+2.3%
2.05
US$20,500
|
10,000
+2.3%
|
2.05
|
US$20,500
|
|
|
2021-11-17 |
2021-11-16 |
B
Purchase
|
EVP, Chief Medical Officer
Officer
|
4,000
+2.4%
2.05
US$8,200
|
4,000
+2.4%
|
2.05
|
US$8,200
|
|
|
2021-11-16 |
2021-11-16 |
B
Purchase
|
CEO and Chairman of the Board
Executive Director
|
3,000
+0.1%
2.06
US$6,180
|
3,000
+0.1%
|
2.06
|
US$6,180
|
|
|
2021-11-15 |
2021-11-15 |
B
Purchase
|
CEO and Chairman of the Board
Executive Director
|
5,000
+0.2%
2.12
US$10,600
|
5,000
+0.2%
|
2.12
|
US$10,600
|
|
|
2021-11-12 |
2021-11-12 |
B
Purchase
|
CEO and Chairman of the Board
Executive Director
|
10,000
+0.3%
2.07
US$20,690
|
10,000
+0.3%
|
2.07
|
US$20,690
|
|
|
2021-10-13 |
2021-10-01 |
B
Purchase
|
Non-Executive Director
|
10,000
+2.5%
2.67
US$26,700
|
10,000
+2.5%
|
2.67
|
US$26,700
|
|
|
2021-09-14 |
2021-09-14 |
B
Purchase
|
Non-Executive Director
|
50,000
+14.2%
3.22
US$161,000
|
50,000
+14.2%
|
3.22
|
US$161,000
|
|
|
2021-05-10 |
2021-05-07 |
B
Purchase
|
Non-Executive Director
|
250
+7.1%
4.50
US$1,125
|
250
+7.1%
|
4.50
|
US$1,125
|
|
|
2021-05-10 |
2021-05-06 |
B
Purchase
|
Non-Executive Director
|
1,700
+94.4%
4.04
US$6,863
|
1,700
+94.4%
|
4.04
|
US$6,863
|
|
|
2021-05-06 |
2021-05-06 |
B
Purchase
|
CEO and Chairman of the Board
Executive Director
|
5,000
+0.2%
3.99
US$19,950
|
5,000
+0.2%
|
3.99
|
US$19,950
|
|
|
2021-04-07 |
2021-04-05 |
B
Purchase
|
Non-Executive Director
|
8,250
+inf%
4.42
US$36,465
|
8,250
+inf%
|
4.42
|
US$36,465
|
|
|
2021-03-08 |
2021-03-04 |
S
Sale
|
President, China Division
Officer
|
419,931
-74.6%
4.52
US$1,898,088
|
419,931
-74.6%
|
4.52
|
US$1,898,088
|
|
|
2021-03-04 |
2021-03-03 |
S
Sale
|
Non-Executive Director
|
98,000
-24.4%
4.75
US$465,500
|
98,000
-24.4%
|
4.75
|
US$465,500
|
|
|
2020-12-01 |
2020-12-01 |
B
Purchase
|
CEO and Chairman of the Board
Executive Director
|
1,000
+0.0%
13.31
US$13,310
|
1,000
+0.0%
|
13.31
|
US$13,310
|
|
|
2020-11-10 |
2020-11-10 |
B
Purchase
|
CEO and Chairman of the Board
Executive Director
|
1,000
+0.0%
11.95
US$11,950
|
1,000
+0.0%
|
11.95
|
US$11,950
|
|
|
2020-11-06 |
2020-11-06 |
B
Purchase
|
CEO and Chairman of the Board
Executive Director
|
5,000
+0.2%
11.70
US$58,500
|
5,000
+0.2%
|
11.70
|
US$58,500
|
|
|
2020-09-24 |
2020-09-24 |
B
Purchase
|
CEO and Chairman of the Board
Executive Director
|
1,000
+0.0%
11.95
US$11,950
|
1,000
+0.0%
|
11.95
|
US$11,950
|
|
|
2020-09-21 |
2020-09-21 |
B
Purchase
|
CEO and Chairman of the Board
Executive Director
Large shareholder
|
1,000
+0.0%
12.42
US$12,420
|
1,000
+0.0%
|
12.42
|
US$12,420
|
|
|
2020-09-14 |
2020-09-14 |
B
Purchase
|
Large shareholder
|
1,800,000
+15.3%
11.00
US$19,800,000
|
1,800,000
+15.3%
|
11.00
|
US$19,800,000
|
|
|
2020-09-14 |
2020-09-14 |
B
Purchase
|
CEO and Chairman of the Board
Executive Director
Large shareholder
|
1,000
+0.0%
11.95
US$11,950
|
1,000
+0.0%
|
11.95
|
US$11,950
|
|
|
2020-09-14 |
2020-09-12 |
B
Purchase
|
Non-Executive Director
|
16,491
+0.8%
11.03
US$181,896
|
16,491
+0.8%
|
11.03
|
US$181,896
|
|
|
2020-09-14 |
2020-09-11 |
B
Purchase
|
Non-Executive Director
|
13,509
+0.7%
11.39
US$153,868
|
13,509
+0.7%
|
11.39
|
US$153,868
|
|
|
2020-09-14 |
2020-09-11 |
B
Purchase
|
CEO and Chairman of the Board
Executive Director
Large shareholder
|
1,000
+0.0%
10.91
US$10,910
|
1,000
+0.0%
|
10.91
|
US$10,910
|
|
|
2020-09-14 |
2020-09-11 |
B
Purchase
|
Non-Executive Director
|
10,000
+2.6%
11.05
US$110,500
|
10,000
+2.6%
|
11.05
|
US$110,500
|
|
|
2020-09-11 |
2020-09-11 |
B
Purchase
|
CEO and Chairman of the Board
Executive Director
Large shareholder
|
2,000
+0.1%
10.99
US$21,978
|
2,000
+0.1%
|
10.99
|
US$21,978
|
|
|
2020-09-14 |
2020-09-10 |
B
Purchase
|
Non-Executive Director
|
10,000
+100.0%
11.35
US$113,500
|
10,000
+100.0%
|
11.35
|
US$113,500
|
|
|
2020-09-14 |
2020-09-10 |
B
Purchase
|
Large shareholder
|
200,000
+1.7%
11.24
US$2,248,000
|
200,000
+1.7%
|
11.24
|
US$2,248,000
|
|
|
2020-09-11 |
2020-09-10 |
B
Purchase
|
Non-Executive Director
|
20,000
+5.4%
11.15
US$223,000
|
20,000
+5.4%
|
11.15
|
US$223,000
|
|
|
2020-09-11 |
2020-09-10 |
B
Purchase
|
Non-Executive Director
|
450
+10.8%
11.49
US$5,170
|
450
+10.8%
|
11.49
|
US$5,170
|
|
|
2020-09-10 |
2020-09-10 |
B
Purchase
|
CEO and Chairman of the Board
Executive Director
Large shareholder
|
10,000
+0.3%
11.22
US$112,200
|
10,000
+0.3%
|
11.22
|
US$112,200
|
|
|
2020-09-10 |
2020-09-10 |
B
Purchase
|
Chief Financial Officer
Officer
|
1,000
+20.0%
11.40
US$11,400
|
1,000
+20.0%
|
11.40
|
US$11,400
|
|
|
2020-06-23 |
2020-06-22 |
PP
Planned purchase
|
EVP, Chief Medical Officer
Officer
|
1,000
+0.7%
12.82
US$12,820
|
1,000
+0.7%
|
12.82
|
US$12,820
|
|
|
2020-06-22 |
2020-06-22 |
B
Purchase
|
CEO and Chairman of the Board
Executive Director
Large shareholder
|
2,000
+0.1%
12.81
US$25,620
|
2,000
+0.1%
|
12.81
|
US$25,620
|
|
|
2020-03-27 |
2020-03-27 |
B
Purchase
|
Chief Financial Officer
Officer
|
1,000
+25.0%
8.19
US$8,190
|
1,000
+25.0%
|
8.19
|
US$8,190
|
|
|
2020-03-27 |
2020-03-27 |
B
Purchase
|
CEO and Chairman of the Board
Executive Director
Large shareholder
|
1,000
+0.0%
7.88
US$7,880
|
1,000
+0.0%
|
7.88
|
US$7,880
|
|
|
2020-03-26 |
2020-03-25 |
B
Purchase
|
Non-Executive Director
|
50,000
+2.6%
7.25
US$362,500
|
50,000
+2.6%
|
7.25
|
US$362,500
|
|
|
2020-03-23 |
2020-03-23 |
B
Purchase
|
CEO and Chairman of the Board
Executive Director
Large shareholder
|
1,000
+0.0%
6.64
US$6,640
|
1,000
+0.0%
|
6.64
|
US$6,640
|
|
|
2020-03-20 |
2020-03-20 |
B
Purchase
|
CEO and Chairman of the Board
Executive Director
Large shareholder
|
1,000
+0.0%
6.85
US$6,850
|
1,000
+0.0%
|
6.85
|
US$6,850
|
|
|
2020-03-19 |
2020-03-19 |
B
Purchase
|
CEO and Chairman of the Board
Executive Director
Large shareholder
|
2,000
+0.1%
6.60
US$13,200
|
2,000
+0.1%
|
6.60
|
US$13,200
|
|
|
2020-03-19 |
2020-03-18 |
PP
Planned purchase
|
EVP, Chief Medical Officer
Officer
|
4,000
+2.9%
5.90
US$23,584
|
4,000
+2.9%
|
5.90
|
US$23,584
|
|
|
2020-03-18 |
2020-03-18 |
B
Purchase
|
CEO and Chairman of the Board
Executive Director
Large shareholder
|
2,000
+0.1%
5.78
US$11,560
|
2,000
+0.1%
|
5.78
|
US$11,560
|
|
|
2020-03-17 |
2020-03-17 |
B
Purchase
|
CEO and Chairman of the Board
Executive Director
Large shareholder
|
2,000
+0.1%
6.90
US$13,800
|
2,000
+0.1%
|
6.90
|
US$13,800
|
|
|
2020-03-16 |
2020-03-16 |
B
Purchase
|
CEO and Chairman of the Board
Executive Director
Large shareholder
|
2,000
+0.1%
7.61
US$15,220
|
2,000
+0.1%
|
7.61
|
US$15,220
|
|
|
2020-03-16 |
2020-03-13 |
B
Purchase
|
Non-Executive Director
|
5,000
+100.0%
8.39
US$41,950
|
5,000
+100.0%
|
8.39
|
US$41,950
|
|
|
2020-03-13 |
2020-03-12 |
PP
Planned purchase
|
EVP, Chief Medical Officer
Officer
|
2,000
+1.5%
8.19
US$16,380
|
2,000
+1.5%
|
8.19
|
US$16,380
|
|
|
2020-03-13 |
2020-03-12 |
B
Purchase
|
CEO and Chairman of the Board
Executive Director
Large shareholder
|
2,000
+0.1%
8.12
US$16,240
|
2,000
+0.1%
|
8.12
|
US$16,240
|
|
|
2020-03-13 |
2020-03-12 |
B
Purchase
|
Non-Executive Director
|
5,000
+inf%
8.34
US$41,700
|
5,000
+inf%
|
8.34
|
US$41,700
|
|
|
2020-03-12 |
2020-03-12 |
B
Purchase
|
CEO and Chairman of the Board
Executive Director
Large shareholder
|
4,000
+0.1%
8.35
US$33,396
|
4,000
+0.1%
|
8.35
|
US$33,396
|
|
|
2020-03-12 |
2020-03-12 |
B
Purchase
|
See Remarks
Officer
|
10,000
+4.8%
8.14
US$81,430
|
10,000
+4.8%
|
8.14
|
US$81,430
|
|
|
2020-03-11 |
2020-03-11 |
B
Purchase
|
Non-Executive Director
|
50,000
+2.7%
10.28
US$513,850
|
50,000
+2.7%
|
10.28
|
US$513,850
|
|
|
2020-03-10 |
2020-03-09 |
PP
Planned purchase
|
EVP, Chief Medical Officer
Officer
|
2,000
+1.5%
9.79
US$19,573
|
2,000
+1.5%
|
9.79
|
US$19,573
|
|
|
2019-12-27 |
2019-12-24 |
B
Purchase
|
PERCEPTIVE ADVISORS LLC
Large shareholder
|
73,698
+0.6%
14.39
US$1,060,514
|
73,698
+0.6%
|
14.39
|
US$1,060,514
|
|
|
2019-12-26 |
2019-12-23 |
B
Purchase
|
PERCEPTIVE ADVISORS LLC
Large shareholder
|
153,237
+1.4%
14.30
US$2,191,289
|
153,237
+1.4%
|
14.30
|
US$2,191,289
|
|
|
2019-12-26 |
2019-12-20 |
B
Purchase
|
PERCEPTIVE ADVISORS LLC
Large shareholder
|
189,322
+1.7%
14.14
US$2,677,013
|
189,322
+1.7%
|
14.14
|
US$2,677,013
|
|
|
2019-12-26 |
2019-12-19 |
B
Purchase
|
PERCEPTIVE ADVISORS LLC
Large shareholder
|
120,931
+1.1%
13.86
US$1,676,104
|
120,931
+1.1%
|
13.86
|
US$1,676,104
|
|
|
2019-12-26 |
2019-12-19 |
B
Purchase
|
PERCEPTIVE ADVISORS LLC
Large shareholder
|
142,812
+1.3%
13.72
US$1,959,381
|
142,812
+1.3%
|
13.72
|
US$1,959,381
|
|
|
2019-12-17 |
2019-12-17 |
B
Purchase
|
Sze Randoll
Chief Financial Officer
Officer
|
1,000
+33.3%
13.25
US$13,250
|
1,000
+33.3%
|
13.25
|
US$13,250
|
|
|
2019-11-12 |
2019-11-07 |
B
Purchase
|
Fok Manson
Non-Executive Director
|
50,000
+2.7%
11.67
US$583,500
|
50,000
+2.7%
|
11.67
|
US$583,500
|
|
|
2019-10-21 |
2019-10-17 |
B
Purchase
|
Large shareholder
|
50,000
+0.5%
10.93
US$546,500
|
50,000
+0.5%
|
10.93
|
US$546,500
|
|
|
2019-10-17 |
2019-10-17 |
B
Purchase
|
Chief Financial Officer
|
1,000
+50.0%
10.99
US$10,990
|
1,000
+50.0%
|
10.99
|
US$10,990
|
|
|
2019-10-18 |
2019-10-16 |
B
Purchase
|
Large shareholder
|
67,222
+0.6%
10.29
US$691,714
|
67,222
+0.6%
|
10.29
|
US$691,714
|
|
|
2019-10-16 |
2019-10-16 |
B
Purchase
|
CEO and Chairman of the Board
Executive Director
Large shareholder
|
6,000
+0.2%
10.16
US$60,960
|
6,000
+0.2%
|
10.16
|
US$60,960
|
|
|
2019-09-30 |
2019-09-30 |
B
Purchase
|
Chief Financial Officer
|
1,000
+100.0%
12.62
US$12,620
|
1,000
+100.0%
|
12.62
|
US$12,620
|
|
|
2019-09-30 |
2019-09-27 |
B
Purchase
|
CEO and Chairman of the Board
Executive Director
Large shareholder
|
3,000
+0.1%
12.85
US$38,550
|
3,000
+0.1%
|
12.85
|
US$38,550
|
|
|
2019-09-23 |
2019-09-23 |
B
Purchase
|
CEO and Chairman of the Board
Executive Director
Large shareholder
|
5,000
+0.2%
13.86
US$69,300
|
5,000
+0.2%
|
13.86
|
US$69,300
|
|
|
2019-09-18 |
2019-09-16 |
B
Purchase
|
Large shareholder
|
30,000
+0.3%
13.58
US$407,400
|
30,000
+0.3%
|
13.58
|
US$407,400
|
|
|
2019-09-16 |
2019-09-16 |
B
Purchase
|
CEO and Chairman of the Board
Executive Director
Large shareholder
|
5,000
+0.2%
13.57
US$67,850
|
5,000
+0.2%
|
13.57
|
US$67,850
|
|
|
2019-09-16 |
2019-09-13 |
B
Purchase
|
Large shareholder
|
56,416
+0.5%
14.27
US$805,056
|
56,416
+0.5%
|
14.27
|
US$805,056
|
|
|
2019-09-16 |
2019-09-12 |
B
Purchase
|
Large shareholder
|
13,584
+0.1%
14.05
US$190,855
|
13,584
+0.1%
|
14.05
|
US$190,855
|
|